Transesophageal vs. intracardiac echocardiographic screening in patients undergoing atrial fibrillation ablation with uninterrupted rivaroxaban

被引:13
|
作者
Tsyganov, A. [1 ]
Shapieva, A. [1 ]
Sandrikov, V. [2 ]
Fedulova, S. [2 ]
Mironovich, S. [1 ]
Dzeranova, A. [2 ]
Lyan, E. [3 ]
机构
[1] Petrovsky Natl Res Ctr Surg, Cardiac Electrophysiol Dept, Abrikosovsky Per 2, Moscow 119991, Russia
[2] Petrovsky Natl Res Ctr Surg, Dept Clin Physiol Radiol & Diagnost Imaging, Abrikosovsky Per 2, Moscow, Russia
[3] Mechnikov North West State Med Univ, Cardiac Electrophysiol Dept, Kirochnaya Ul 41, St Petersburg 191015, Russia
来源
BMC CARDIOVASCULAR DISORDERS | 2017年 / 17卷
关键词
NOAC; Transesophageal echocardiography; ICE; Atrial fibrillation; Catheter ablation; RADIOFREQUENCY ABLATION; GUIDED CARDIOVERSION; CATHETER ABLATION; THROMBUS; SAFETY; COMPLICATIONS; MANAGEMENT; EFFICACY;
D O I
10.1186/s12872-017-0607-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Patients with atrial fibrillation (AF) routinely undergo different imaging modalities for the evaluation of the left atrial (LA) appendage to rule out thrombus prior to the AF ablation procedure. Recently, uninterrupted novel oral anticoagulants were introduced for patients undergoing atrial fibrillation (AF) ablation to minimize the peri-procedural thromboembolism risk. We performed a retrospective analysis to evaluate the safety of uninterrupted rivaroxaban and whether transesophageal (TEE) or intracardiac echocardiography (ICE) is necessary for patients undergoing AF ablation. Methods: Data from 332 consecutive patients (42% females, aged 64 +/- 11 years) with AF undergoing either TEE (n = 115) prior to catheter ablation or ICE (n = 217) for the detection of LA thrombus were analyzed. All patients were on uninterrupted rivaroxaban during, and for at least, 4 weeks before the procedure. Heparin bolus was administered in all patients before transseptal puncture to maintain a target activated clotting time of >350 s. Results: A total of 277 patients (80.4%) had paroxysmal AF. The average CHA2DS2VASc score was 2.11 +/- 0.91 in the TEE group and 2.46 +/- 0.61 in the ICE group. The CHA2DS2VASc score was >= 2 in 64 (55.7%) and 214 (98.6%) patients in the TEE and ICE groups, respectively. The left atrial appendage was adequately visualized in all cases. None of the patients have an identifiable LA thrombus either in the TEE group or the ICE group. One (0.3%) thromboembolic periprocedural stroke occurred in a patient with long-standing persistent AF in the TEE group. Conclusions: This study illustrates that performing AF ablation with ICE guidance on uninterrupted rivaroxaban for at least 4 weeks even without TEE is feasible and safe.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Transesophageal vs. intracardiac echocardiographic screening in patients undergoing atrial fibrillation ablation with uninterrupted rivaroxaban
    A. Tsyganov
    A. Shapieva
    V. Sandrikov
    S. Fedulova
    S. Mironovich
    A. Dzeranova
    E. Lyan
    BMC Cardiovascular Disorders, 17
  • [2] Uninterrupted novel anticoagulants as safe alternative of transesophageal echocardiographic screening in patients undergoing ablation for atrial fibrillation
    Shapieva, A.
    Tsyganov, A.
    Lyan, E.
    Fedulova, S.
    Mironovich, S.
    Fetisova, E.
    Chaykovskaya, M.
    Dzeranova, A.
    Sandrikov, V.
    EUROPEAN HEART JOURNAL, 2017, 38 : 577 - 577
  • [3] Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation
    Cappato, Riccardo
    Marchlinski, Francis E.
    Hohnloser, Stefan H.
    Naccarelli, Gerald V.
    Xiang, Jim
    Wilber, David J.
    Ma, Chang-Sheng
    Hess, Susanne
    Wells, Darryl S.
    Juang, George
    Vijgen, Johan
    Huegl, Burkhard J.
    Balasubramaniam, Richard
    De Chillou, Christian
    Davies, D. Wyn
    Fields, L. Eugene
    Natale, Andrea
    EUROPEAN HEART JOURNAL, 2015, 36 (28) : 1805 - 1811
  • [4] Feasibility and Safety of Uninterrupted Rivaroxaban for Periprocedural Anticoagulation in Patients Undergoing Radiofrequency Ablation for Atrial Fibrillation
    Lakkireddy, Dhanunjaya
    Reddy, Yeruva Madhu
    Di Biase, Luigi
    Vallakati, Ajay
    Mansour, Moussa C.
    Santangeli, Pasquale
    Gangireddy, Sandeep
    Swarup, Vijay
    Chalhoub, Fadi
    Atkins, Donita
    Bommana, Sudharani
    Verma, Atul
    Sanchez, Javier E.
    Burkhardt, J. David
    Barrett, Conor D.
    Baheiry, Salwa
    Ruskin, Jeremy
    Reddy, Vivek
    Natale, Andrea
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (10) : 982 - 988
  • [5] Feasibility and Safety of Uninterrupted Rivaroxaban in Patients Undergoing Radiofrequency Ablation for Long Standing Persistent Atrial Fibrillation
    Di Biase, Luigi
    Trivedi, Chintan
    Mohanty, Prasant
    Mohanty, Sanghamitra
    Bai, Rong
    Santangeli, Pasquale
    Sanchez, Javier
    Horton, Rodney
    Gallinghouse, G. Joseph
    Zagrodzky, Jason
    Hao, Steven
    Hongo, Richard
    Beheiry, Salwa
    Lakkireddy, Dhanujaya R.
    Reddy, Madhu
    Viles-Gonzalez, Juan F.
    Burkhardt, J. David
    Natale, Andrea
    CIRCULATION, 2014, 130
  • [6] Transesophageal Echocardiographic Assessment of Pulmonary Veins and Left Atrium in Patients Undergoing Atrial Fibrillation Ablation
    Stavrakis, Stavros
    Madden, George
    Pokharel, Dipesh
    Po, Sunny S.
    Nakagawa, Hiroshi
    Jackman, Warren M.
    Sivaram, Chittur A.
    ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES, 2011, 28 (07): : 775 - 781
  • [7] Apixaban, Rivaroxaban, and Dabigatran in Patients Undergoing Atrial Fibrillation Ablation
    Rillig, Andreas
    Lin, Tina
    Plesman, Joaquina
    Heeger, Christian-H.
    Lemes, Christine
    Metzner, Andreas
    Mathew, Shibu
    Wissner, Erik
    Wohlmuth, Peter
    Ouyang, Feifan
    Kuck, Karl-Heinz
    Tilz, Roland Richard
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2016, 27 (02) : 147 - 153
  • [8] Rivaroxaban and dabigatran in patients undergoing catheter ablation of atrial fibrillation
    Providencia, Rui
    Marijon, Eloi
    Albenque, Jean-Paul
    Combes, Stephane
    Combes, Nicolas
    Jourda, Francois
    Hireche, Hassiba
    Morais, Joao
    Boveda, Serge
    EUROPACE, 2014, 16 (08): : 1137 - 1144
  • [9] Interrupted or Uninterrupted Oral Anticoagulants in Patients Undergoing Atrial Fibrillation Ablation
    Yang, Pingping
    Wang, Chenxi
    Ye, Yinquan
    Huang, Tieqiu
    Yang, Shuai
    Shen, Wen
    Xu, Gaosi
    Wu, Qinghua
    CARDIOVASCULAR DRUGS AND THERAPY, 2020, 34 (03) : 371 - 381
  • [10] Interrupted or Uninterrupted Oral Anticoagulants in Patients Undergoing Atrial Fibrillation Ablation
    Pingping Yang
    Chenxi Wang
    Yinquan Ye
    Tieqiu Huang
    Shuai Yang
    Wen Shen
    Gaosi Xu
    Qinghua Wu
    Cardiovascular Drugs and Therapy, 2020, 34 : 371 - 381